Overview
Status
Active
Registry date
2024-04-09
Share capital
5,000.00 PLN
Registered address
ul. Tarczyńska 8, 02-019 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Mohamed Salah Hegazyage 42 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mohamed Salah Hegazyage 42 | 100 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company Ultra Tech Company.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
The main business activity of Ultra Tech Company focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on April 9, 2024.
The headquarters is located at: ul. Tarczyńska 8, 02-019 Warszawa.
The management board consists of: Mohamed Salah Hegazy (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-10-07